Noticed: Odesa and Kyiv-based startup A.D.A.M has a daring and impressive mission – to make it attainable to deal with any a part of the human physique as a replaceable half. The corporate makes use of the analogy of a automotive store, the place sufferers can substitute physique elements like they’d a damaged fan belt.
This will likely sound like a lofty aim, however the firm is making speedy progress. Because the firm’s basis in 2018, the preliminary focus has been on growing bone implants utilizing proprietary 3D printing know-how. This know-how has already handed pre-clinical trials in wistar rats, and the corporate is at the moment awaiting additional regulatory clearances with the aim of starting gross sales in 2022.
One of many key advantages of A.D.A.M’s know-how is that the implants could be tailor-made to particular affected person wants. The corporate has created a digital platform the place sufferers can add and securely retailer their MRI and CAT scans. Medical doctors can then use this data to create a 3D mannequin of the implant, which is then used as the premise for manufacturing.
Manufacturing of the implants by means of 3D printers can both happen on the firm’s services or immediately on web site relying on the wants of every medical establishment. The method is quick, taking as much as 24 hours. Using 3D printing and the corporate’s specifically designed materials composites additionally considerably lowers the price of manufacturing in comparison with titanium or PEEK-based implants.
Following manufacturing, medical professionals obtain a sterilised implant that’s prepared for rapid use in surgical procedure. The implants are biodegradable and are step by step changed by bone over time. Which means that sufferers don’t want a second operation to take away the implant at a later date.
Bone implants are simply step one in A.D.A.M’s plans. The corporate web site states that analysis into blood vessel, coronary heart valve, and bronchial implants would be the precedence within the coming years.
Written By: Matthew Hempstead